Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity

Rhea-AI Summary

Labcorp (NYSE: LH) introduced an enhanced digital version of its Labcorp Global Trial Connect™ platform, covering the Labcorp Sponsor™ and Labcorp Investigator™ portals. The redesign aims to improve visibility across clinical studies, simplify workflows and support faster decision-making for sponsors and investigator sites.

According to Labcorp, the upgrade was guided by feedback from more than 80 sponsors and 100 investigator sites. Key additions include a more intuitive, role-based interface; streamlined study management tools; embedded in-portal kit ordering that can reduce manual data entry by 75%; and a unified Study Oversight Dashboard integrating study, site, sample and supply insights.

The platform also adds a guided Report Wizard for customized reports and end-to-end sample lifecycle tracking. Labcorp positions these enhancements as part of ongoing digital investment within its Biopharma Laboratory Services business to support more efficient, high-quality clinical trial delivery.

Positive

• Embedded in-portal kit ordering targets a 75% reduction in manual data entry
• Enhancements informed by feedback from 80+ sponsors and 100 investigator sites
• New unified Study Oversight Dashboard centralizes study, site, sample and supply insights in one view
• End-to-end sample lifecycle tracking enhances sample visibility for clinical trials

Negative

• None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Enhanced digital experience designed to improve visibility, simplify workflows and support faster decision-making

BURLINGTON, N.C., Aug. 31, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory solutions, today announced enhancements to the digital experience of Labcorp Global Trial Connect™, the company's portfolio of clinical trial services, data and technology that enhances and accelerates delivery. The newly redesigned platform introduces new capabilities across the Labcorp Sponsor™ and Labcorp Investigator™ portal experiences of Global Trial Connect, providing greater visibility across studies, simplifying workflows and helping sponsors and investigator sites make faster, more informed decisions.

"As clinical trials become increasingly complex, sponsors and investigator sites need technology that helps them work more effectively," said Brian Caveney, M.D., EVP and president, Biopharma Laboratory Services and chief medical and scientific officer, Labcorp. "The latest enhancements to Global Trial Connect make it easier to access insights, manage study activities and navigate trial complexity with confidence, allowing customers to focus less on operational tasks and more on advancing research and supporting patients."

Designed with Customers, for Customers
Guided by input from more than 80 sponsors and 100 investigator sites worldwide, the latest enhancements to Global Trial Connect were informed by extensive customer feedback, product testing and direct input. Key updates include:

• A more intuitive user experience with simplified navigation and role-based customization
• Streamlined study management with integrated tools for study oversight, reporting and supply tracking
• Embedded in-portal kit ordering that reduces manual data entry by 75% while optimizing inventory oversight and management
• Greater visibility into study performance through a unified Study Oversight Dashboard that brings together study, site, sample and supply insights in a single view
• Simplified report creation with a new Report Wizard that guides users through building and customizing reports to meet their needs
• Enhanced sample visibility through end-to-end tracking across the sample lifecycle

Advancing the Future of Clinical Trial Delivery
These enhancements represent the latest milestone in Labcorp's ongoing investment in digital solutions across its Biopharma Laboratory Services business, helping sponsors and investigator sites deliver high-quality clinical trials more efficiently. Through continued collaboration with customers, Labcorp will further evolve Global Trial Connect to address emerging industry challenges and provide a more connected experience across the clinical trial lifecycle.

To learn more about the latest capabilities and watch an overview video of the enhancements, visit the Global Trial Connect page https://www.labcorp.com/biopharma/central-labs/global-trial-connect.

About Labcorp 
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than 85% of the new drugs and therapeutic products approved by the FDA in 2025 and performed more than 750 million tests for patients around the world. Learn more at www.labcorp.com. 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-launches-next-generation-of-labcorp-global-trial-connect-to-help-sponsors-and-investigator-sites-navigate-clinical-trial-complexity-302864646.html

SOURCE Labcorp

FAQ

What did Labcorp (NYSE: LH) announce about Global Trial Connect on August 31, 2026?

Labcorp announced an enhanced digital experience for its Global Trial Connect™ platform, including redesigned Sponsor and Investigator portals. According to Labcorp, the update improves study visibility, simplifies workflows, and supports faster decision-making for sponsors and investigator sites across the clinical trial lifecycle.

What are the key new features in Labcorp’s Global Trial Connect™ upgrade for LH shareholders to know?

The upgrade adds a more intuitive, role-based interface, streamlined study management tools, and a unified Study Oversight Dashboard. According to Labcorp, it also introduces embedded kit ordering, a guided Report Wizard, and end-to-end sample tracking to support more efficient clinical trial operations.

How does the new Labcorp Global Trial Connect™ reduce manual work in clinical trials?

The platform now includes embedded in-portal kit ordering designed to reduce manual data entry by 75%. According to Labcorp, this integration optimizes inventory oversight and management, helping sponsors and investigator sites lessen administrative tasks and focus more on research and patient support.

How was the updated Labcorp Global Trial Connect™ platform designed with sponsors and sites?

The enhancements were guided by input from more than 80 sponsors and 100 investigator sites worldwide. According to Labcorp, extensive customer feedback, product testing, and direct user input shaped features like navigation, dashboards, reporting tools, and workflow simplification in the new release.

How does Labcorp’s upgraded Global Trial Connect™ support complex clinical trials?

The platform offers unified study oversight, end-to-end sample tracking, and streamlined reporting to help manage complexity. According to Labcorp, these tools give sponsors and investigator sites faster access to insights, enabling more informed decisions and potentially more efficient delivery of high-quality clinical trials.

What reporting improvements are included in Labcorp’s latest Global Trial Connect™ release?

The release adds a new Report Wizard that guides users through building and customizing reports. According to Labcorp, this feature simplifies report creation and, together with the Study Oversight Dashboard, helps consolidate study, site, sample, and supply data into actionable views for trial teams.